Donta L. Wilson
Known title: DirectorCIK: 0001681329
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Truist reports strong Q3 earnings amid leadership changes. Truist Financial Corporation beat third-quarter earnings estimates, joining other regional banks in posting solid results. The company also announced a leadership shakeup, with its consumer-bank chief departing. These developments occurred while the broader market faced volatility, with the Nasdaq posting a significant weekly drop.
Transaction History
| SIG | ▲ Buy | Grant | 9 | $0 | 8/21/2026 | View on chart |
| TFC | ▼ Sell | Open Market | 13,280 | $689K | 7/31/2026 | View on chart |
| SIG | ▲ Buy | Grant | 2,018 | $0 | 6/26/2026 | View on chart |
| SIG | ▲ Buy | Grant | 9 | $0 | 5/22/2026 | View on chart |
| TFC | ▼ Sell | Tax Withholding | 10,204 | $447K | 3/13/2026 | View on chart |
| TFC | ▲ Buy | Grant | 3,216 | $0 | 2/23/2026 | View on chart |
| TFC | ▲ Buy | Grant | 1,102 | $0 | 2/23/2026 | View on chart |
| TFC | ▲ Buy | Grant | 6,930 | $0 | 2/23/2026 | View on chart |
| TFC | ▲ Buy | Grant | 12,236 | $0 | 2/23/2026 | View on chart |
| SIG | ▲ Buy | Grant | 7 | $0 | 2/20/2026 | View on chart |
| SIG | ▲ Buy | Grant | 7 | $0 | 11/21/2025 | View on chart |
| TFC | ▼ Sell | Gift | 230 | $0 | 10/23/2025 | View on chart |
| SIG | ▲ Buy | Grant | 8 | $0 | 8/22/2025 | View on chart |
| SIG | ▲ Buy | Grant | 2,014 | $0 | 7/1/2025 | View on chart |
| TFC | ▼ Sell | Tax Withholding | 13,020 | $528K | 3/14/2025 | View on chart |
| TFC | ▲ Buy | Grant | 1,102 | $0 | 2/24/2025 | View on chart |
| TFC | ▲ Buy | Grant | 3,119 | $0 | 2/24/2025 | View on chart |
| TFC | ▲ Buy | Grant | 6,930 | $0 | 2/24/2025 | View on chart |
| TFC | ▲ Buy | Grant | 11,506 | $0 | 2/24/2025 | View on chart |
| TFC | ▲ Buy | Grant | 3,913 | $0 | 2/24/2025 | View on chart |
| TFC | ▲ Buy | Grant | 3,216 | $0 | 2/24/2025 | View on chart |
| SIG | ▲ Buy | Grant | 1,641 | $0 | 6/28/2024 | View on chart |
| TFC | ▼ Sell | Tax Withholding | 7,588 | $265K | 3/15/2024 | View on chart |
| TFC | ▲ Buy | Grant | 1,900 | $0 | 2/26/2024 | View on chart |
| TFC | ▲ Buy | Grant | 3,120 | $0 | 2/26/2024 | View on chart |
| TFC | ▲ Buy | Grant | 3,217 | $0 | 2/26/2024 | View on chart |
| TFC | ▲ Buy | Grant | 1,103 | $0 | 2/26/2024 | View on chart |
| TFC | ▲ Buy | Grant | 7,960 | $0 | 2/26/2024 | View on chart |
| SIG | ▲ Buy | Grant | 2,467 | $0 | 6/16/2023 | View on chart |
| TFC | ▼ Sell | Tax Withholding | 6,905 | $222K | 3/15/2023 | View on chart |
| TFC | ▼ Sell | Gift | 114 | $0 | 3/8/2023 | View on chart |
| TFC | ▲ Buy | Grant | 10,599 | $0 | 2/27/2023 | View on chart |
| TFC | ▲ Buy | Grant | 3,121 | $0 | 2/27/2023 | View on chart |
| TFC | ▲ Buy | Grant | 1,899 | $0 | 2/27/2023 | View on chart |
| SIG | ▲ Buy | Grant | 2,667 | $0 | 6/17/2022 | View on chart |
| TFC | ▼ Sell | Tax Withholding | 4,156 | $241K | 3/15/2022 | View on chart |
| TFC | ▲ Buy | Grant | 1,899 | $0 | 2/21/2022 | View on chart |
| TFC | ▲ Buy | Grant | 5,575 | $0 | 2/21/2022 | View on chart |
| TFC | ▲ Buy | Grant | 1,875 | $0 | 2/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher
Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher. Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.